Dean Augustine M.K. Choi proudly presents:
Fourth Annual Symposium on Entrepreneurship and Academic Drug Development
This symposium is designed for faculty, trainees, and students interested in advancing their research from the lab to the clinic.
Learn about ways to partner with industry and the resources available at BioPharma Alliances and Research Collaborations, the Tri-Institutional Therapeutics Discovery Institute, Bridge Medicines, and the Center for Technology Licensing.
Register here:
https://weillcornell.zoom.us/meeting/register/tJElc-usrT8jHtWyO0TMQKfPNNNKRFOrNL3A
Keynote Address by:
John Maraganore, PhD
Chief Executive Officer, Alnylam Pharmaceuticals
Alnylam has led the translation of RNAi (RNA interference) from Nobel Prize-winning discovery into an innovative, entirely new class of medicines.
Featured Speakers:
John P. Leonard, MD
Senior Associate Dean for Innovation and Initiatives
Richard T. Silver Distinguished Professor of Hematology and Medical Oncology
Weill Cornell Medicine
“Updates on Weill Cornell Medicine’s Innovation Ecosystem”
and
Li Gan, PhD
Director, Helen and Robert Appel Alzheimer’s Disease Research Institute
Burton P. and Judith B. Resnick Distinguished Professor in Neurodegenerative Diseases, Feil Family Brain and Mind Research Institute
Weill Cornell Medicine
“Developing New Therapeutics for Neurodegenerative Disease”